[go: up one dir, main page]

SG10201801156RA - Beta-casein a2 and blood glucose levels - Google Patents

Beta-casein a2 and blood glucose levels

Info

Publication number
SG10201801156RA
SG10201801156RA SG10201801156RA SG10201801156RA SG10201801156RA SG 10201801156R A SG10201801156R A SG 10201801156RA SG 10201801156R A SG10201801156R A SG 10201801156RA SG 10201801156R A SG10201801156R A SG 10201801156RA SG 10201801156R A SG10201801156R A SG 10201801156RA
Authority
SG
Singapore
Prior art keywords
casein
beta
blood glucose
glucose levels
levels
Prior art date
Application number
SG10201801156RA
Inventor
Andrew John Clarke
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52483940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201801156R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of SG10201801156RA publication Critical patent/SG10201801156RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A23V2250/54246—Casein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Animal Husbandry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
SG10201801156RA 2013-08-23 2014-08-22 Beta-casein a2 and blood glucose levels SG10201801156RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361869213P 2013-08-23 2013-08-23

Publications (1)

Publication Number Publication Date
SG10201801156RA true SG10201801156RA (en) 2018-03-28

Family

ID=52483940

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201600670VA SG11201600670VA (en) 2013-08-23 2014-08-22 Beta-casein a2 and blood glucose levels
SG10201801156RA SG10201801156RA (en) 2013-08-23 2014-08-22 Beta-casein a2 and blood glucose levels

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201600670VA SG11201600670VA (en) 2013-08-23 2014-08-22 Beta-casein a2 and blood glucose levels

Country Status (17)

Country Link
US (2) US10568933B2 (en)
EP (2) EP3035951B2 (en)
JP (2) JP6866159B2 (en)
KR (2) KR102270059B1 (en)
CN (1) CN105555295A (en)
AU (2) AU2014309522B2 (en)
CA (2) CA2920152A1 (en)
ES (1) ES2899732T5 (en)
IL (2) IL243845B (en)
MX (2) MX376874B (en)
MY (1) MY192873A (en)
NZ (1) NZ717171A (en)
PH (2) PH12019550262A1 (en)
RU (1) RU2698794C2 (en)
SG (2) SG11201600670VA (en)
WO (1) WO2015026245A1 (en)
ZA (1) ZA201600816B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX376874B (en) 2013-08-23 2025-03-07 A2 Milk Co Ltd BETA-CASEIN A2 AND BLOOD GLUCOSE LEVELS.
CN107708718B (en) * 2015-04-22 2022-01-11 西达-赛奈医疗中心 Enterally delivered bitter oligopeptides for the treatment of type 2 diabetes
CN107708711A (en) * 2015-05-22 2018-02-16 艾尔牛奶有限公司 β caseins A2 and oxidation resistance
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
MX2018007819A (en) * 2015-12-22 2018-12-17 A2 Milk Co Ltd Infant formula comprising human milk peptides.
JP2017165661A (en) * 2016-03-14 2017-09-21 雪印メグミルク株式会社 Glucose metabolism improving agent
NZ746167A (en) 2016-03-30 2023-04-28 A2 Milk Co Ltd Beta-caseins and cognitive function
CA3036494C (en) 2016-09-30 2022-10-18 The A2 Milk Company Limited Beta-caseins and gut microbiota
CN113248628B (en) * 2021-07-13 2021-10-22 南京市妇幼保健院 Milk-derived polypeptide derivative and application thereof in preparation of obesity prevention and treatment medicines, health-care products and food additives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2204245C (en) * 1994-11-04 2008-07-22 Robert Bartlett Elliott Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
DE69634831T2 (en) * 1995-05-16 2006-06-29 A2 Corp. Ltd., Newmarket FOOD AND MANUFACTURING PROCESS
US7094949B2 (en) * 1995-05-16 2006-08-22 A2 Corporation Limited Breeding and milking cows for milk free of β-casein A1
JP2003503038A (en) * 1999-06-29 2003-01-28 ザ・ニュージーランド・ミルク・インスティチュート・リミテッド Preventive supplements based on milk
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
KR20050060057A (en) * 2002-07-03 2005-06-21 에이2 코포레이션 리미티드 Method for altering fatty acid composition of milk
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
RU2007105884A (en) * 2004-07-19 2008-08-27 Н.В. Нютрисиа (Nl) DRUG FOR APPLICATION OF Aspartate and Vitamin B12 or Biotin for the regulation of ketone bodies
EP2745709A1 (en) * 2012-12-24 2014-06-25 Abbott Laboratories, Inc. Nutritional compositions with reduced beta-casein a1 and related methods
MX376874B (en) 2013-08-23 2025-03-07 A2 Milk Co Ltd BETA-CASEIN A2 AND BLOOD GLUCOSE LEVELS.

Also Published As

Publication number Publication date
WO2015026245A1 (en) 2015-02-26
ES2899732T3 (en) 2022-03-14
JP6866159B2 (en) 2021-04-28
SG11201600670VA (en) 2016-02-26
KR20160044580A (en) 2016-04-25
US20200129590A1 (en) 2020-04-30
IL257228B (en) 2020-02-27
RU2016103489A (en) 2017-09-28
JP7082551B2 (en) 2022-06-08
US10568933B2 (en) 2020-02-25
MX376874B (en) 2025-03-07
ZA201600816B (en) 2017-11-29
EP3035951B2 (en) 2024-09-04
HK1225618A1 (en) 2017-09-15
EP3035951B1 (en) 2021-09-15
RU2016103489A3 (en) 2018-06-18
AU2014309522B2 (en) 2019-11-07
EP3035951A1 (en) 2016-06-29
KR102270059B1 (en) 2021-06-28
CA3235298A1 (en) 2015-02-26
KR20210022776A (en) 2021-03-03
US20160324922A1 (en) 2016-11-10
CA2920152A1 (en) 2015-02-26
RU2698794C2 (en) 2019-08-30
MX2016002372A (en) 2016-12-20
EP3943100A1 (en) 2022-01-26
PH12019550262A1 (en) 2023-02-20
AU2019204101A1 (en) 2019-07-04
MY192873A (en) 2022-09-13
AU2019204101B2 (en) 2021-09-02
NZ717171A (en) 2022-05-27
MX2020006720A (en) 2020-08-20
IL257228A (en) 2018-03-29
EP3035951A4 (en) 2017-04-19
JP2019011342A (en) 2019-01-24
IL243845B (en) 2018-02-28
PH12016500213A1 (en) 2016-04-25
KR102626825B1 (en) 2024-01-17
JP2016532702A (en) 2016-10-20
CN105555295A (en) 2016-05-04
IL243845A0 (en) 2016-04-21
ES2899732T5 (en) 2025-02-05
PH12016500213B1 (en) 2021-08-04
AU2014309522A1 (en) 2016-03-10

Similar Documents

Publication Publication Date Title
IL269877B (en) Blood pump systems and methods
SG11201506213VA (en) Non-invasive blood analysis
IL257228B (en) Beta-casein a2 and blood glucose levels
SG11201510561QA (en) Patient interface and aspects thereof
IL243310B (en) Juice extractor and juice extractor body
GB201314953D0 (en) Catheter Assembley
EP3398549C0 (en) Basket catheter with deflectable spine
SG11201604537UA (en) Implantable biosensor
GB2510497B (en) Catheter
EP2990010A4 (en) Artificial blood vessel
GB201305761D0 (en) Blood Pump
EP2965723A4 (en) Medical stent
EP2950101A4 (en) Blood glucose meter
GB201305758D0 (en) Blood Pump
IL243247A0 (en) An unravelable catheter
EP2949274A4 (en) Heart treatment device
IL233698B (en) Multishape catheter
GB201307872D0 (en) Medical use
EP2950100A4 (en) Blood glucose meter
ZA201503834B (en) Identifying subjects in need of treatment
GB201309498D0 (en) Novel diagnosis and therapy
AU355656S (en) Blood glucose meter
CL2016000287A1 (en) Levels of beta-casein a2 and blood glucose
PH32015001049S1 (en) Blood glucose meter
GB201519112D0 (en) Sensing blood glucose levels